Kerendia®▼ (finerenone) and the Kidneys
Breaking Barriers in CKD Management

Welcome to our Kerendia and the Kidneys - Breaking Barriers in CKD Management short video series.
Kidney expert Dr Albert Power covers critical areas in the management in your CKD patients:
- Part One | Diagnosing and understanding the risks of CKD.
- Part Two | Optimising management in CKD in T2D.
- Part Three | What is Kerendia and why should we prescribe it?
- Part Four | What Is the profile of a potential Kerendia patient?
- Part Five | Prescribing Kerendia: Initiation, continuation and hyperkalaemia management.
These concise sessions are packed with insights relevant to both primary and secondary care.
We would love to hear your feedback on these videos to help us shape future resources for the future- feedback form
Prescribing information for Kerendia®▼(finerenone) can be found here.
CKD=chronic kidney disease; MOD=mechanism of disease; MOA=mechanism of action.
PP-KER-GB-0798 | February 2025